
JASZONE-1.5
Composition: Ceftriaxone Sodium I.P.1000 mg + Sulbactum Sodium I.P. 500 mg
Dosage Form: Injection
Packaging Type :
Packaging: 1S with Carton
M.R.P. Rs. :
DESCRIPTION
SIDE EFFECTS
INDICATION
IMPORTANT NOTICE
DESCRIPTION
JASZONE-SB 1.5 is a powerful combination of Ceftriaxone, a third-generation cephalosporin antibiotic, and Sulbactam, a β-lactamase inhibitor. Ceftriaxone kills bacteria by interfering with the formation of their cell walls, while Sulbactam protects Ceftriaxone from being broken down by β-lactamase enzymes produced by resistant bacteria.
This synergistic combination extends the antibacterial spectrum and enhances the effectiveness against resistant strains.
SIDE EFFECTS
Most side effects are mild and temporary. However, consult your doctor if symptoms persist or worsen.
Common side effects may include:
Pain, redness, or swelling at the injection site
Diarrhea or upset stomach
Rash or itching
Elevated liver enzymes
Nausea or vomiting
Headache
Allergic reactions (rare but serious)
Seek immediate medical help in case of severe allergic symptoms like facial swelling, difficulty breathing, or severe rash.
INDICATION
JASZONE-SB 1.5 is used in the treatment of moderate to severe infections such as:
Lower respiratory tract infections (e.g., pneumonia, bronchitis)
Urinary tract infections (UTIs)
Intra-abdominal infections
Skin and soft tissue infections
Bone and joint infections
Gynecological infections
Bacterial septicemia
Post-operative and hospital-acquired infections
IMPORTANT NOTICE
To be administered by a qualified healthcare professional only via IV or IM route.
Not to be used in individuals allergic to penicillins or cephalosporins.
Use with caution in patients with kidney or liver disorders—dose adjustments may be required.
Safe use in pregnancy and lactation should be done only under medical supervision.
Do not skip doses and complete the entire course to prevent resistance.
Store in a cool, dry place, protected from light.
Do not self-administer.